Author:
Shen Shunli,Peng Hong,Wang Ye,Xu Ming,Lin Manxia,Xie Xiaoyan,Peng Baogang,Kuang Ming
Funder
the Fundamental Research Funds for the Central Universities
the Science and Technology Project of Guangzhou
Natural Science Foundation of Guangdong Province
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference22 articles.
1. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208–36.
2. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365(12):1118–27.
3. Tiong L, Maddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg. 2011;98(9):1210–24.
4. Waitz R, Solomon SB. Can local radiofrequency ablation of tumors generate systemic immunity against metastatic disease. Radiology. 2009;251(1):1–2.
5. Wissniowski TT, Hänsler J, Neureiter D, Frieser M, Schaber S, Esslinger B, Voll R, Strobel D, Hahn EG, Schuppan D, Wissniowski TT, Hünsler J. Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. Cancer Res. 2003;63(19):6496–500.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献